Ramaco Resources, Inc. entered into Third Amended and Restated Credit and Security Agreement with KeyBank National Association, as administrative agent, collateral agent, lender, swing line lender and issuer valued at $350,000,000 (effective 2025-12-30).
“On December 30, 2025, Ramaco Resources, Inc. (the “Company”) entered into a Third Amended and Restated Credit and Security Agreement (the “Third A&R Credit Agreement”) with KeyBank National Association, as administrative agent, collateral agent, lender, swing line lender and issuer (the “Agent”),”
BACKIMAC Holdings, Inc.
IMAC Holdings, Inc. entered into Securities Purchase Agreement with Cavalry Fund I SPV I LP, C/M Capital Master Fund LP, and Cavalry Fund I LP valued at $7,530,929.74 (effective 2025-12-19).
“On December 19, 2025, IMAC Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Cavalry Fund I SPV I LP, C/M Capital Master Fund LP, and Cavalry Fund I LP (collectively, the “Buyers”), pursuant to which the Company agreed to issue and sell to the Buyers senior secured notes (the “Notes”) in the aggregate original principal amount of $7,530,929.74.”
VREOFVireo Growth Inc.
Vireo Growth Inc. entered into Agreement and Plan of Merger with Eaze Inc. valued at approximately US$47 million in base consideration (effective 2025-12-22).
“On December 22, 2025, Vireo Growth Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with respect to a business combination with Eaze Inc., a Delaware corporation (“Eaze”) pursuant to which, following the closing of the business combination with Eaze (the “Merger”), the Company will issue a number of subordinate voting shares in consideration for all of the issued and outstanding shares of Eaze equal to the amount of the Estimated Closing Merger Consideration (as defined in the Merger Agreement) divided by US$0.56, subject to a post-closing purchase price adjustment with respect to certain of the estimated items included in the Estimated Closing Merger Consideration.”
EZRAReliance Global Group, Inc.
Reliance Global Group, Inc. entered into Purchase Agreement with Employee Benefit Solutions Inc valued at $1,050,000 in cash (effective 2025-12-23).
“On December 23, 2025, Reliance Global Group, Inc., a Florida corporation (the “Company”), Employee Benefits Solutions, LLC, a Michigan limited liability company, and US Benefits Alliance, LLC, a Michigan limited liability company (collectively, the “Seller”), each of which is a wholly owned subsidiary of the Company, and Employee Benefit Solutions Inc, a Michigan corporation (the “Purchaser”), entered into an Asset Purchase Agreement (the “Purchase Agreement”)”
PCTPureCycle Technologies, Inc.
PureCycle Technologies, Inc. amended Seventh Supplemental Indenture with Southern Ohio Port Authority, UMB Bank, N.A. (effective 2025-12-26).
“On December 26., 2025, SOPA, as Issuer, PCO, PureCycle Technologies LLC, an indirect wholly-owned subsidiary of the Company (the “Guarantor”), PCTO Holdco LLC, a Delaware limited liability company and affiliate of PCO (the pledgor under the Equity Pledge and Security Agreement) and the Trustee entered into the Seventh Supplemental Indenture (the “Seventh Supplemental Indenture”), which amended certain provisions of the Indenture and Loan Agreement.”
“On December 23, 2025, Barings Private Credit Corporation (“Company”) entered into an amended and restated senior secured revolving credit agreement (the “SMBC Revolving Credit Agreement”), by and among the Company, as borrower, the lenders and issuing banks party thereto and Sumitomo Mitsui Banking Corporation (“SMBC”), as administrative agent, lead arranger and sole bookrunner, which amended that certain Senior Secured Revolving Credit Revolving Agreement, dated as of March 6, 2023”
ADVBAdvanced Biomed Inc.
Advanced Biomed Inc. entered into Share Purchase Agreement with Wei Ha Hui valued at Purchase price of US$23,000 for 100% of Advanced Biomed (HK) Limited (effective 2025-12-23).
“On December 23, 2025, Advanced Biomed Inc. (the “ Company ”) entered into an agreement (the “ Agreement ”) with an unrelated third party, Wei Ha Hui (the “ Buyer ”), pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed (HK) Limited, a Hong Kong company and a wholly owned subsidiary of the Company (the “ Hong Kong Subsidiary ”), for an aggregate purchase price of US$23,000 based on a valuation report commissioned by the Company, subject to the terms and conditions set forth in the Agreement.”
Willow Tree Capital Corp
Willow Tree Capital Corp amended Second Amendment and Joinder to Amended and Restated Loan, Security and Collateral Management Agreement with Ally Bank, as administrative agent and arranger, and State Street Bank and Trust Company, as collateral custodian valued at $500,000,000 to $575,000,000 (effective 2025-12-23).
“On December 23, 2025, WT Capital Fund – SPV1, LLC (“ Capital Fund – SPV ”), a Delaware limited liability company and wholly-owned subsidiary of the Willow Tree Capital Corporation (the " Company "), entered into a Second Amendment and Joinder to Amended and Restated Loan, Security and Collateral Management Agreement (the " Second Amendment "), which amends the Amended and Restated Loan, Security and Collateral Management Agreement, dated as of November 8, 2024, by and between the Company, as collateral manager and transferor, Capital Fund - SPV, as borrower, each of the lenders from time to time party thereto, Ally Bank, as administrative agent and arranger, and State Street Bank and Trust Company, as collateral custodian (the " A&R Credit Facility ").”
EQT Exeter Real Estate Income Trust, Inc.
EQT Exeter Real Estate Income Trust, Inc. entered into Property Management Agreement with EQT Real Estate Advisors, LLC (effective 2025-12-23).
“In connection with the acquisition of the Torrance Property, on December 23, 2025, the Company, through the Torrance Buyer, entered into a property management agreement with EQT Real Estate Advisors, LLC (the “Property Manager”), an affiliate of the Adviser (the “Property Management Agreement”).”
EQT Exeter Real Estate Income Trust, Inc.
EQT Exeter Real Estate Income Trust, Inc. entered into a asset purchase with Frito-Lay Sales, Inc. valued at approximately $51.5 million (effective 2025-12-19).
“On December 19, 2025, EQT Real Estate, LLC (the “Adviser”), the Company’s external adviser, entered into a purchase and sale agreement in connection with a sale-leaseback transaction with Frito-Lay Sales, Inc. (the “Torrance Seller”), an affiliate of PepsiCo, Inc., to acquire the Torrance Property.”
HLEOHelio Corp /FL/
Helio Corp /FL/ entered into Purchase Agreements with two institutional investors (effective 2025-12-19).
“On December 19, 2025, Helio Corp. (the “Company”) entered into purchase agreements (the “Purchase Agreements”) with two institutional investors, pursuant to which the Company issued promissory notes.”
AESIAtlas Energy Solutions Inc.
Atlas Energy Solutions Inc. amended Fourth Amendment to Loan, Security and Guaranty Agreement with Bank of America, N.A., as administrative agent (effective 2025-12-26).
“On December 26, 2025, Atlas Sand Company, LLC (“Atlas LLC”) and certain other subsidiaries of the Company entered into that certain Fourth Amendment to Loan, Security and Guaranty Agreement (the “Fourth ABL Amendment”), among Atlas LLC, as the borrower, the subsidiary guarantors party thereto, the lenders party thereto and Bank of America, N.A., as administrative agent.”
AESIAtlas Energy Solutions Inc.
Atlas Energy Solutions Inc. entered into Interim Funding Agreement with Stonebriar Commercial Finance LLC valued at up to $385.0 million (effective 2025-12-26).
“and an Interim Funding Agreement (the “Interim Funding Agreement” and, together with the Lease Agreement, the “Lease Documents”), by and between Galt and Stonebriar, pursuant to which Galt assigned a reservation agreement (the “Reservation Agreement”) for the manufacture of approximately 240 megawatts of power generation equipment (the “Equipment”) to Stonebriar and Stonebriar agreed to lease such power generation equipment back to Galt (the “Transaction”).”
AESIAtlas Energy Solutions Inc.
Atlas Energy Solutions Inc. entered into Master Lease Agreement with Stonebriar Commercial Finance LLC valued at up to $385.0 million (effective 2025-12-26).
“On December 26, 2025, Atlas Energy Solutions Inc., a Delaware corporation (the “Company”), entered into a Master Lease Agreement (the “Lease Agreement”) by and between Galt Power Solutions LLC, a Texas limited liability company and indirect wholly-owned subsidiary of the Company (“Galt”), as lessee, and Stonebriar Commercial Finance LLC, a Delaware limited liability company (“Stonebriar”), as lessor”
MDCXMedicus Pharma Ltd.
Medicus Pharma Ltd. entered into Equity Distribution Agreement with Maxim Group LLC and Yorkville Securities, LLC valued at up to $15,349,674 (effective 2025-12-29).
“On December 29, 2025, Medicus Pharma Ltd. (the "Company") entered into an Equity Distribution Agreement (the "Agreement") with Maxim Group LLC ("Maxim") and Yorkville Securities, LLC ("Yorkville Securities" and together with Maxim, the "Agents") to create an at-the-market equity program.”
5C Lending Partners Corp.
5C Lending Partners Corp. amended Second Amendment with U.S. Bank National Association (effective 2025-12-19).
“On December 19, 2025, 5C Lending Partners Corp., a Maryland corporation (the “Company”), entered into a second amendment to its revolving credit agreement (the “Second Amendment”)”
KIDZClassover Holdings, Inc.
Classover Holdings, Inc. entered into Exchange Agreement with institutional investor valued at Exchange of $2,000,000 of Senior Secured Convertible Notes for 2,000 shares of Series C Convertible (effective 2025-12-29).
“On December 29, 2025, Classover Holdings Inc., a Nevada corporation (the “ Company ”), entered into an Exchange Agreement (the “ Exchange Agreement ") with an institutional investor who is the holder of its Senior Secured Convertible Notes issued on June 6, 2025 (the “ Notes ”) pursuant to a Securities Purchase Agreement, dated as of May 30, 2025, between the Company and the Holder (the “ SPA ”). The Exchange Agreement provides, among other things, for the Holder to initially exchange (the “ Initial Exchange ”) $2,000,000 of the Notes (including principal and interest) for 2,000 shares of the Company’s Series C Convertible Preferred Stock, par value $0.0001 per share (the “ Series C Preferred Stock ”), and, upon the mutual written agreement of the Company and the Holder, for the Holder to subsequently exchange additional amounts of the Notes (including principal, interest and other amounts outstanding with respect thereto) for additional shares of Series C Preferred Stock (the “ Additi”
PMIPicard Medical, Inc.
Picard Medical, Inc. entered into engagement letter with WestPark Capital, Inc..
“In connection with the Private Placement, the Company entered into an engagement letter with WestPark Capital, Inc. (“WestPark”), pursuant to which WestPark acted as the Company’s exclusive placement agent.”
PMIPicard Medical, Inc.
Picard Medical, Inc. entered into Security Agreement (effective 2025-12-26).
“In connection with the Purchase Agreement and the issuance of the Notes, (i) the Company entered into a Security Agreement, dated as of the Initial Closing (the “Security Agreement”), pursuant to which the Company granted a first-priority security interest in substantially all of the tangible and intangible assets of the Company and certain of its US subsidiaries, subject to permitted liens and exceptions, to secure the Company’s Obligations (as defined in the Security Agreement) under the Note Documents (as defined in the Security Agreement) and related transaction documents”
PMIPicard Medical, Inc.
Picard Medical, Inc. entered into Notes with a single institutional investor valued at an aggregate principal amount of $15,000,000 (effective 2025-12-26).
“On December 26, 2025 (the “Initial Closing”), the Company, pursuant to the Purchase Agreement, issued the Initial Purchased Notes (as defined in the Purchase Agreement) in an aggregate principal amount of $15,000,000, as the first draw under a notes facility.”
PMIPicard Medical, Inc.
Picard Medical, Inc. entered into Purchase Agreement with a single institutional investor (effective 2025-12-24).
“On December 24, 2025, Picard Medical, Inc. (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with a single institutional investor (the “Buyer”), pursuant to which the Company agreed to issue and sell, in a private placement exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) of Regulation D, promulgated thereunder (the “Private Placement”): (i) senior secured notes of the Company due December 26, 2028 (the “Notes”) and (ii) warrants (the “Warrants” and together with the Notes, the “Securities”) to purchase 7,009,346 shares of the Company’s common stock”
VWAVVisionWave Holdings, Inc.
VisionWave Holdings, Inc. entered into Promissory Note with C.M. Composite Materials Ltd. valued at $398,345 (effective 2025-12-26).
“On December 26, 2025, VisionWave Holdings, Inc. (the "Company") advanced principal in the amount of $398,345 to C.M. Composite Materials Ltd., an Israeli corporation ("CM"). In connection with the advance, CM delivered a Promissory Note to the Company (the "Note").”
VNOMViper Energy, Inc.
Viper Energy, Inc. amended Amended and Restated Limited Liability Company Agreement of New OpCo with affiliates of Diamondback Energy, Inc., Tumbleweed Royalty IV, LLC, NGU Management LLC and EnCap Energy Capital Fund X, L.P..
“VNOM Sub, Inc., a wholly owned subsidiary of Viper, in its capacity as the managing member of New OpCo, along with affiliates of Diamondback Energy, Inc., Tumbleweed Royalty IV, LLC, NGU Management LLC and EnCap Energy Capital Fund X, L.P. adopted the Amended and Restated Limited Liability Company Agreement of New OpCo (the “New OpCo LLC Agreement”).”
VNOMViper Energy, Inc.
Viper Energy, Inc. entered into Omnibus Transaction Agreement with the Merging Entities and Old OpCo (effective 2025-12-23).
“On December 23, 2025, Old OpCo and New OpCo entered into an Omnibus Transaction Agreement (the “Omnibus Agreement”), by and among Sitio Permian, LP, Sitio Appalachia, LP, Sitio Nuevo, LP, Sitio Anadarko, LP, Moccasin Royalty LLC, Queen Snake Royalty LLC, King Snake Royalty LLC, 1979 Royalties GP, LLC, Mamba Royalty LP, 1979 Royalties, LP and VNOM Merger Sub LP (collectively, the “Merging Entities”), Old OpCo, and solely with respect to Section 4 thereof, New OpCo, pursuant to which, among other things, (i) the Merging Entities merged with and into Old OpCo and (ii) Old OpCo merged with and into a wholly owned subsidiary of VNOM Sub, Inc.”
FONRFONAR CORP
FONAR CORP entered into Agreement and Plan of Merger with FONAR, LLC valued at $19.00 per share for Company Common Stock and Company Class B Common Stock; $6.34 per share for Comp (effective 2025-12-23).
“On December 23, 2025, FONAR Corporation, a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with FONAR, LLC, a Delaware limited liability company (“Parent”), and FONAR Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which, subject to the satisfaction of the conditions set forth in the Merger Agreement, Parent will acquire all of the issued and outstanding shares of the Company”
LEELEE ENTERPRISES, Inc
LEE ENTERPRISES, Inc entered into Stock Purchase Agreement with David Hoffmann and certain additional investors valued at Issuance of 15,384,615 shares of common stock at $3.25 per share for aggregate gross proceeds of app (effective 2025-12-30).
“On December 30, 2025, Lee Enterprises, Incorporated (the “Company”) entered into a stock purchase agreement (the “Purchase Agreement”) with David Hoffmann (the “Anchor Investor”) and certain additional investors (the “Other Investors” and, together with the Anchor Investor, the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors in a private placement (the “Private Placement”) an aggregate of 15,384,615 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a purchase price of $3.25 per share.”
LWAYLifeway Foods, Inc.
Lifeway Foods, Inc. amended Sixth Modification to the Amended and Restated Loan and Security Agreement with CIBC Bank USA (effective 2025-12-29).
“On December 29, 2025, Lifeway Foods, Inc. (“Lifeway”), Fresh Made, Inc., a wholly-owned subsidiary of Lifeway (“Fresh Made”), Lifeway Wisconsin, Inc., a wholly-owned subsidiary of Lifeway (“Lifeway Wisconsin” and, together with Lifeway and Fresh Made, the “Borrowers”), and CIBC Bank USA, the Borrowers’ current lender (the “Lender”) entered into the Sixth Modification to the Amended and Restated Loan and Security Agreement (the “Sixth Modification”).”
POSCPOSITRON CORP
POSITRON CORP entered into Subscription Agreement with a single investor valued at Two Million Dollars ($2,000,000) (effective 2025-12-23).
“On December 23, 2025, Positron Corporation (the “Company”) entered into a Subscription Agreement with a single investor to purchase 1,333,333 shares (the “Shares”) of the Company’s common stock”
FCELFUELCELL ENERGY INC
FUELCELL ENERGY INC amended Open Market Sale Agreement SM with Jefferies LLC, B. Riley Securities, Inc., Barclays Capital Inc., BMO Capital Markets Corp., BofA Securities, Inc., Canaccord Genuity LLC, Citigroup Global Markets Inc. and Loop Capital Markets LLC valued at $200,000,000 (effective 2025-12-30).
“On December 30, 2025, FuelCell Energy, Inc. (the “Company”) entered into an amendment to the Open Market Sale Agreement SM (as amended, the “Sales Agreement”) with Jefferies LLC, B. Riley Securities, Inc., Barclays Capital Inc., BMO Capital Markets Corp., BofA Securities, Inc., Canaccord Genuity LLC, Citigroup Global Markets Inc. and Loop Capital Markets LLC, as sales agents, to increase the amount of shares of common stock that may be sold under the Sales Agreement to $200,000,000 (exclusive of any sales made prior to the date of the amendment).”
DYNAVAX TECHNOLOGIES CORP
DYNAVAX TECHNOLOGIES CORP entered into Agreement and Plan of Merger with Sanofi (effective 2025-12-23).
“On December 23, 2025, Dynavax Technologies Corporation, a Delaware corporation (the “ Company ” or “ Dynavax ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among the Company, Sanofi, a French soci é t é anonyme (“ Parent ”) and Samba Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Purchaser ”).”
VLGEAVILLAGE SUPER MARKET INC
VILLAGE SUPER MARKET INC entered into Loan Agreement with NJCC CDE 49 LLC (effective 2025-12-19).
“On December 19, 2025, Village Super Market, Inc. (the “Company”) entered into a financing transaction with Valley National Bank Community Investment Fund, LLC (“Valley Bank”) under a qualified New Markets Tax Credit (“NMTC”) program related to the construction of a replacement store in East Orange, New Jersey.”
PTCTPTC THERAPEUTICS, INC.
PTC THERAPEUTICS, INC. amended Amendment No. 2 to Amended and Restated Royalty Purchase Agreement with Royalty Pharma Investments 2019 ICAV valued at $240.0 million in upfront cash consideration (effective 2025-12-29).
“On December 29, 2025, PTC Therapeutics, Inc. (the “Company”), Royalty Pharma Investments 2019 ICAV (“RPI”), and, for the limited purposes set forth in the Purchase Agreement (as defined below), Royalty Pharma plc, entered into an Amendment No. 2 to Amended and Restated Royalty Purchase Agreement (the “Amendment”), which amends that certain Amended and Restated Royalty Purchase Agreement, dated as of October 18, 2023, as amended by Amendment No. 1 dated June 17, 2024 (the “Purchase Agreement”).”
WULFTERAWULF INC.
TERAWULF INC. entered into purchase agreement with Morgan Stanley & Co. LLC valued at $1.3 billion (effective 2025-12-18).
“The notes were sold under a purchase agreement, dated as of December 18, 2025, entered into by and among Flash Compute, Abernathy Data LLC (the “Guarantor”), and Morgan Stanley & Co. LLC, as representative of the initial purchasers thereto (the “Initial Purchasers"), for resale to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act") or, outside the United States, to persons other than “U.S. persons" in compliance with Regulation S under the Securities Act.”
WULFTERAWULF INC.
TERAWULF INC. entered into Indenture with Wilmington Trust, National Association valued at $1.3 billion (effective 2025-12-29).
“On December 29, 2025, JV Partners Holdco, Flash Compute and the Guarantor entered into an indenture (the “Indenture”) with respect to the notes with Wilmington Trust, National Association, as trustee (the “Trustee”).”
ONCOR ELECTRIC DELIVERY CO LLC
ONCOR ELECTRIC DELIVERY CO LLC entered into Term Loan Agreement with Sumitomo Mitsui Banking Corporation, as administrative agent, and the lenders from time to time party thereto valued at $1.4 billion (effective 2025-12-23).
“On December 23, 2025, Oncor Electric Delivery Company LLC (“Oncor”) entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) among Oncor, as borrower, the lenders from time to time party thereto, and Sumitomo Mitsui Banking Corporation, as administrative agent for the lenders. The Term Loan Agreement provides for a term loan credit facility in an aggregate principal amount of $1.4 billion”
DYAIDYADIC INTERNATIONAL INC
DYADIC INTERNATIONAL INC amended Amendment (effective 2025-12-23).
“On December 23, 2025, Dyadic International, Inc. (the “Company”) entered into an amendment (the “Amendment”) to the Form of Senior Secured Convertible Promissory Note due March 8, 2027 (the “Convertible Notes”).”
ModivCare Inc
ModivCare Inc entered into Purchase Agreement with the Buyer (unnamed in excerpt) valued at ModivCare transferred substantially all assets to the Buyer in exchange for restructuring considerat (effective 2025-12-29).
“On the Effective Date, ModivCare entered into the Purchase Agreement with the Buyer, as contemplated by and consistent with the Plan.”
ModivCare Inc
ModivCare Inc entered into Exit Term Loan Credit Agreement (including Super Senior Exit Term Loan Credit Facility and Takeback Term Loan Credit Facility) with Wilmington Trust, National Association as administrative and collateral agent valued at $100,000,000 super senior secured term loan facility and $300,000,000 takeback term loan facility, m (effective 2025-12-29).
“On the Effective Date, certain affiliates of the Company acquired by the Buyer on the Effective Date pursuant to the Purchase Agreement entered into certain exit financing arrangements contemplated by the Plan with the Buyer as borrower, ModivCare Intermediate, LLC (“ModivCare Intermediate”), and Wilmington Trust, National Association as administrative and collateral agent (the “Exit Term Loan Credit Agreement”) consisting of a new money super senior secured term loan facility in an aggregate principal amount of $100,000,000 (the “Super Senior Exit Term Loan Credit Facility”) and a second-out senior secured term loan facility consisting of $300,000,000 in takeback term loans (the “Takeback Term Loan Credit Facility” and, together with the Super Senior Exit Term Loan Credit Facility, the “Exit Term Loan Credit Facilities” and the documents pertaining thereto, the “Exit Facilities Documents”).”
Novelis Inc.
Novelis Inc. entered into subscription agreement with AV Minerals (Netherlands) N.V. valued at $750 million (effective 2025-12-23).
“On December 23, 2025, Novelis Inc. (the “Company”) entered into a subscription agreement with AV Minerals (Netherlands) N.V. (“AV Minerals”), the Company’s sole shareholder and a wholly owned subsidiary of Hindalco Industries Limited, pursuant to which AV Minerals agreed to purchase 5,000,000 of the Company’s common shares, no par value per share, for $750 million at a price of $150 per share.”
IBRXImmunityBio, Inc.
ImmunityBio, Inc. amended Amendment No. 1 with Jefferies LLC valued at $459,972,480 (effective 2025-12-23).
“On December 23, 2025, ImmunityBio, Inc. (the “Company”) entered into Amendment No. 1 (the “Amendment to Sale Agreement”) to the Open Market Sale Agreement SM dated April 30, 2021, (the “Sale Agreement”) with Jefferies LLC (the “Agent”) relating to the sale and issuance of shares of its common stock, par value $0.0001 per share (the “Shares”), from time to time through an “at the market” offering program under which the Agent acts as the Company’s sales agent.”
ORNOrion Group Holdings Inc
Orion Group Holdings Inc terminated Prior Credit Agreement with White Oak ABL, LLC and White Oak Commercial Finance, LLC valued at approximately $1.1 million (effective 2025-12-23).
“On December 23, 2025, in connection with entering into the Credit Agreement, the Company’s prior Credit Agreement, dated May 15, 2023, with White Oak ABL, LLC and White Oak Commercial Finance, LLC (the “Prior Credit Agreement) was terminated, and all amounts outstanding thereunder were repaid.”
ORNOrion Group Holdings Inc
Orion Group Holdings Inc entered into Credit Agreement with certain financial institutions from time-to-time party thereto, as lenders, and UMB Bank, N.A., as Administrative Agent and Issuing Bank valued at $120.0 million (effective 2025-12-23).
“On December 23, 2025, Orion Group Holdings, Inc., as borrower (the “Company”) entered into a $120.0 million Credit Agreement (the “Credit Agreement”) with certain financial institutions from time-to-time party thereto, as lenders, and UMB Bank, N.A., as Administrative Agent and Issuing Bank (the “Agent”).”
EFCEllington Financial Inc.
Ellington Financial Inc. entered into Equity Distribution Agreements (amendments and new agreements) with Citizens JMP Securities, LLC, B. Riley Securities, Inc., BTIG, LLC, Armstrong Securities LLC, Citadel Securities Institutional LLC, Moelis & Company LLC valued at Maximum aggregate offering price of up to $500 million of common stock (effective 2025-12-23).
“On December 23, 2025, Ellington Financial Inc. (the “Company”) and Ellington Financial Management LLC, the Company’s manager (the "Manager"), entered into separate amendments (each an "Amendment" and collectively, the "Amendments") to its existing equity distribution agreements dated September 30, 2024 (collectively, as amended, the "Existing Sales Agreements") with each of Citizens JMP Securities, LLC (“Citizens JMP”), B. Riley Securities, Inc. (“B. Riley Securities”), BTIG, LLC (“BTIG”) and Armstrong Securities LLC ("Armstrong") relating to the Company’s previously announced at the market common stock offering program (the “Offering").”
TNXPTonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. entered into Placement Agency Agreement with TD Securities (USA) LLC valued at 6.0% cash placement fee on gross proceeds; expense reimbursement up to $100,000 (effective 2025-12-29).
“On December 29, 2025, the Company entered into a placement agency agreement (the "Placement Agency Agreement") with TD Securities (USA) LLC (the "Placement Agent"), pursuant to which the Placement Agent was engaged as the placement agent for the Offering.”
TNXPTonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. entered into Securities Purchase Agreement with a single institutional investor valued at $20.0 million gross proceeds; offering price per Share $16.26, per Pre-Funded Warrant $16.259 (effective 2025-12-29).
“On December 29, 2025, Tonix Pharmaceuticals Holding Corp. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with a single institutional investor (the "Purchaser").”
VRSKVerisk Analytics, Inc.
Verisk Analytics, Inc. terminated Term Credit Agreement with Bank of America N.A., as administrative agent, and the lenders party thereto valued at $750,000,000 (effective 2025-12-26).
“Term Facility Termination As previously reported on August 15, 2025 the Company entered into a Term Credit Agreement (the “Term Credit Agreement”), among the Company, the lenders party thereto and Bank of America N.A., as administrative agent.”
VRSKVerisk Analytics, Inc.
Verisk Analytics, Inc. terminated Agreement and Plan of Merger with ExactLogix, Inc. and Richard Spanton, Jr., as Equityholders' Representative (effective 2025-12-26).
“On December 26, 2025, the Company delivered a notice to ExactLogix and the Equityholders’ Representative terminating the Merger Agreement because the Merger was not consummated on or before December 26, 2025.”
RKDAArcadia Biosciences, Inc.
Arcadia Biosciences, Inc. terminated Securities Exchange Agreement with Roosevelt Resources, LP (effective 2025-12-24).
“On December 24, 2025, the Company received a notice from Roosevelt indicating that it was terminating the Exchange Agreement with immediate effect pursuant to the Termination Provisions”
BOXLBoxlight Corp
Boxlight Corp amended Eleventh Amendment to Credit Agreement with Whitehawk Finance LLC (effective 2025-12-18).
“On December 18, 2025, Boxlight Corporation, a Nevada corporation (the “Company”), and its subsidiaries entered into the Eleventh Amendment to Credit Agreement (the “Eleventh Amendment”) with Whitehawk Finance LLC, as the lender (the “Lender”) and Whitehawk Capital Partners LP, as administrative agent and collateral agent (the “Agent”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.